# S-1 in Combination With Abraxane in Treating Cholangiocarcinoma

> **NCT01963325** · PHASE2 · COMPLETED · sponsor: **Yuhong Li** · enrollment: 50 (actual)

## Conditions studied

- Cholangiocarcinoma

## Interventions

- **DRUG:** S-1 plus Abraxane

## Key facts

- **NCT ID:** NCT01963325
- **Lead sponsor:** Yuhong Li
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01963325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01963325, "S-1 in Combination With Abraxane in Treating Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01963325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*